Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1829 (LINC01829) is a long non-coding RNA gene located on human chromosome 2p14. LINC01829 belongs to the class of intergenic lncRNAs, which are autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes. The specific biological function of LINC01829 is currently uncharacterized, and it is not considered a therapeutic target or biomarker at present. Broadly, lincRNAs may regulate gene expression, modulate chromatin architecture, and participate in transcriptional regulation, but there are no experimental studies describing the function, disease association, or drug interactions for LINC01829 specifically.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1829 (LINC01829).